PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript

PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.

Related Keywords

Brazil ,France ,United States ,Japan ,America ,Eric Pauwels ,Matthew Klein ,Kylie Okeefe ,Lisa Milberg ,Pierre Gravier ,Joseph Thome ,Deric Joseph ,William Blair ,Sami Corwin ,Kelly Shi ,Kristen Kluska ,Samantha Corwin ,Jane Hanlon ,Cantor Fitzgerald ,European Commission ,Therapeutics Inc ,Ptc Therapeutics Inc ,Nasdaq ,Exchange Commission ,Call Transcript April ,Results Conference ,Associate Director ,Chief Executive Officer ,Chief Business Officer ,Chief Commercial Officer ,Kylieo Keefe ,Chief Financial Officer ,Investor Relations ,Executive Director ,Latin America ,Middle East ,North Africa ,Asia Pacific ,Highest Student Loan Debt ,Conservative States ,Ptc Therapeutics ,